Cas 13141-96-3,<i>N</i>-(4-ethoxy-phenyl)-<i>N</i>'-(3-nitro-phenyl)-urea

13141-96-3

Post Buying Request

Basic information

Product Name: N-(4-ethoxy-phenyl)-N'-(3-nitro-phenyl)-urea
Synonyms:
CAS NO:13141-96-3
Molecular Formula:
Molecular Weight: 301.302
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(4-ethoxy-phenyl)-N'-(3-nitro-phenyl)-urea(CAS DataBase Reference)
NIST Chemistry Reference: N-(4-ethoxy-phenyl)-N'-(3-nitro-phenyl)-urea(13141-96-3)
EPA Substance Registry System: N-(4-ethoxy-phenyl)-N'-(3-nitro-phenyl)-urea(13141-96-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 13141-96-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

13141-96-3 Suppliers

Recommended suppliers

13141-96-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13141-96-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,4 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13141-96:
(7*1)+(6*3)+(5*1)+(4*4)+(3*1)+(2*9)+(1*6)=73
73 % 10 = 3
So 13141-96-3 is a valid CAS Registry Number.

13141-96-3Upstream product

13141-96-3Downstream Products

13141-96-3Relevant academic research and scientific papers

DIARYL UREAS AS CB1 ANTAGONISTS

-

Page/Page column 132, (2008/06/13)

Compounds of Formula I are provided. In which the variables are as described herein. Such compounds may be used to modulate CB1 activity in vivo or in vitro, and are particularly useful in the treatment of conditions responsive to CB1 modulation in humans, domesticated companion animals and livestock animals, including appetite disorders, obesity and addictive disorders. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies and various in vitro assays.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 13141-96-3